Using AI software to diagnose retinopathy of prematurity in infants
Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)
This study is testing a smart computer program that helps doctors quickly and accurately check for a serious eye condition in premature babies, with the goal of preventing blindness and making sure the program works safely in real-life situations.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Siloam Vision, INC. NIH-funded |
| Lab location | 1 site (Lake Oswego, United States) |
| Project ID | NIH-10931442 on NIH RePORTER |
What this research studies
This research aims to validate an artificial intelligence (AI) software designed to diagnose retinopathy of prematurity (ROP), a serious eye condition that can lead to blindness in premature infants. The AI algorithm analyzes images from a specialized camera to provide expert-level diagnosis quickly and accurately. By integrating this technology into clinical workflows, healthcare providers can receive immediate diagnostic support, potentially preventing blindness in at-risk infants. The project includes updating the AI algorithm for better performance and conducting clinical studies to ensure its effectiveness and safety.
Who could benefit from this research
Good fit: Ideal candidates for this research are premature infants under the age of 11 who are at risk for developing retinopathy of prematurity.
Not a fit: Patients who are not premature or do not have risk factors for retinopathy of prematurity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of preventable blindness in premature infants by enabling timely and accurate diagnosis of ROP.
How similar studies have performed: Previous research has shown success with AI-based diagnostic tools in other medical fields, indicating a promising potential for this novel approach in diagnosing ROP.
Where this research is happening
Lake Oswego, United States
- Siloam Vision, INC. — Lake Oswego, United States (Active)
Researchers
- Principal investigator: Jonas, Karyn — Siloam Vision, INC.
- Study coordinator: Jonas, Karyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.